Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Rapport Therapeutics, Inc. - Common Stock (NQ:RAPP)

26.94 -1.99 (-6.88%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 466,946
Open 28.76
Bid (Size) 26.35 (3,700)
Ask (Size) 28.20 (1,100)
Prev. Close 28.93
Today's Range 26.35 - 29.49
52wk Range 6.430 - 42.27
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Rapport Therapeutics to Participate in TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit
From Rapport Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
 
Via Benzinga

Performance

YTD
+46.5%
+46.5%
1 Month
-2.9%
-2.9%
3 Month
+91.9%
+91.9%
6 Month
+145.4%
+145.4%
1 Year
+14.1%
+14.1%

More News

Read More
Rapport Announces Pricing of Public Offering of Common Stock
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Rapport Therapeutics Stock Rockets 204% Pre-Market To Head Toward All-Time Highs – Here’s What Happened
Via Stocktwits
Let's take a look at the stocks that are in motion in today's session.
Via Chartmill
Rapport Announces Proposed Public Offering of Common Stock
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Top movers analysis one hour before the close of the markets on 2025-09-08: top gainers and losers in today's session.
Via Chartmill
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Top stock movements in today's session.
Via Chartmill
Gold Moves Higher; Robinhood Shares Jump
Via Benzinga
Rapport Therapeutics, Planet Labs, QuantumScape, EchoStar And Other Big Stocks Moving Higher On Monday
Via Benzinga
Nasdaq Surges 150 Points; Planet Labs Shares Jump After Q2 Results
Via Benzinga
Rapport Catapults Almost 200% After Succeeding In Hard-To-Treat Seizures
Via Investor's Business Daily
Rapport Reports Promising Epilepsy Study Outcomes, Plans Phase 3 Trials Next Year
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Rapport Announces Positive Topline Results from Phase 2a Clinical Trial of RAP-219 in Patients with Focal Onset Seizures
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Friday's after hours session: top gainers and losers
Via Chartmill
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025
From Rapport Therapeutics, Inc.
Via GlobeNewswire
Phibro Animal Health, Pure Storage, Snowflake, Build-A-Bear Workshop And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Rapport (RAPP) Q2 Net Loss Widens 47%
Via The Motley Fool
Rapport Therapeutics Inc (NASDAQ:RAPP) Reports Narrower-Than-Expected Q2 2025 Loss Amid Clinical Progress
Via Chartmill
Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update
From Rapport Therapeutics, Inc.
Via GlobeNewswire
This Palvella Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
Via Benzinga

Frequently Asked Questions

Is Rapport Therapeutics, Inc. - Common Stock publicly traded?
Yes, Rapport Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Rapport Therapeutics, Inc. - Common Stock trade on?
Rapport Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Rapport Therapeutics, Inc. - Common Stock?
The ticker symbol for Rapport Therapeutics, Inc. - Common Stock is RAPP on the Nasdaq Stock Market
What is the current price of Rapport Therapeutics, Inc. - Common Stock?
The current price of Rapport Therapeutics, Inc. - Common Stock is 26.94
When was Rapport Therapeutics, Inc. - Common Stock last traded?
The last trade of Rapport Therapeutics, Inc. - Common Stock was at 11/03/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.